EFFECT OF SLEEP APNEA SYNDROME ON QT DISPERSION AND QT CORRECTED INTERVAL IN PATIENTS WITH TYPE 2 DIABETES
Journal Title: Romanian Journal of Diabetes Nutrition and Metabolic Diseases - Year 2011, Vol 18, Issue 1
Abstract
Objective. Prolonged QT interval and increased QT interval dispersion (QTd) are well-characterized precursor of malignant ventricular arrhythmias. The aim of the present study was to assess QT interval corrected for heart rate (QTc) and QTd in patients with type 2 diabetes and sleep apnea syndrome (SAS) comparative with patients with type 2 diabetes without sleep apnea. Methods. 52 subjects with type 2 diabetes were included in the study. According to apnea-hypopnea index (AHI) patients were divided into three groups: 1) control subjects (AHI < 5/hour of sleep); 2) patients with mild SAS (AHI=5-15/hour of sleep) and 3) patients with moderate–severe SAS (AHI≥15/hour of sleep). Bazett’s formula (QTc=QT/√RR) was used to obtain heart rate corrected values of the QT intervals and dispersions. Results. Prevalence of increased QTc interval in the whole population was 19.2% (10.5% in control group and 26.1% in moderate/severe SAS group). The mean QTd was 52.7 ms in all patients, with values increasing from 40.0 ms in controls to 64.8 ms in group with moderate-severe SAS. Statistically significant positive association was found between QTd and oxygen desaturation index (ODI) (β=0.38, p=0.006) and between QTd and AHI (β=0.29, p=0.03). In addition, a statistically significant negative association was found between QTd and mean SaO2 (β= -0.40, p=0.003) and between QTd and minimum SaO2 (β= -0.43, p=0.001). After adjustment for confounding factors, AHI, ODI, mean SaO2 and minimum SaO2 remained statistically significant associated with QTd. Conclusion. Sleep apnea is associated with changes in QT interval variability in patients with type 2 diabetes. Increased severity of SAS, as deter¬mined by AHI, may result in inhomogeneity of repolarization, favoring ventricular tachyarrhytmias.
Authors and Affiliations
Adriana Rusu, Cristina Nita, Cornelia Bala, Nicolae Hancu
THE DATABASE OF THE PATIENTS WITH DIABETES REGISTERED AT THE CLINICAL CENTER FOR DIABETES, NUTRITION AND METABOLIC DISEASES CLUJ
A database concerning the treatment and some demographical data requested by the National House of Health Insurance, of the more than 18000 patients attending the Diabetes Centre in Cluj is presented below, with its main...
THERAPY WITH GLP-1 AGONISTS AND DIPEPTIDYL-PEPTIDASE IV INHIBITORS IN TYPE 2 DIABETES MELLITUS
Since type 2 diabetes is increasing and most patients do not reach their therapeutic goals, novel treatment options are needed. The novel therapeutic options for type 2 diabetes mellitus (Type 2 DM); respectively those b...
SLEEPING WITH THE ENEMY
ENDOTHELIAL PROGENITOR CELLS – ROLE IN ATHEROGENESIS
PANCREAS TRANSPLANTATION – BENEFITS AND RISKS FOR DIABETIC PATIENTS
Pancreas transplantation is considered a valuable therapeutic option in diabetic patients, either alone or combined with renal allografts in transplant candidates with imminent or established end-stage renal disease. Imp...